Hanneke Schuitemaker, PhD, Vice President and Head of Viral Vaccines Discovery and Translational Medicine at Janssen Vaccines, explains the challenges faced when creating a vaccine for HIV. Dr. Schuitemaker explains that one of the hardest tasks involves dealing with the "variability of the virus," and since a vaccine for HIV has not been developed yet, researchers are left working through trial-and-error.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512